MedTrace Logo

Ragweed Observational Study

NCT01398137 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2011-10-27

No results posted yet for this study

Summary

This is an observational to evaluate Total Rhinoconjunctivitis Symptom Score and rescue medication usage (as measured by Rescue Medication Score as a Combined Score to inform the design of a phase III field study with ToleroMune Ragweed.

Conditions

  • Ragweed Allergy

Sponsors & Collaborators

  • Quintiles, Inc.

    collaborator INDUSTRY

  • Circassia Limited

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01398137 on ClinicalTrials.gov